Cargando…

Cuprotosis Patterns Are Associated with Tumor Mutation Burden and Immune Landscape in Lung Adenocarcinoma

BACKGROUND: The association involving cuprotosis, molecular subtype, and specific immune cell groups in the tumor microenvironment has been focused on by more recent studies. In lung adenocarcinoma (LUAD), the potential functions of cuprotosis remain elusive. METHODS: The cuprotosis regulations and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Tingting, Cai, Liangliang, Hua, Hujia, Jiang, Xingyu, Xu, Xintian, Zhang, Tianyi, Huang, Wenqing, Qian, Li, Bai, Hua, Duan, Jianchun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9711958/ https://www.ncbi.nlm.nih.gov/pubmed/36467497 http://dx.doi.org/10.1155/2022/9772208

Ejemplares similares

MMR gene patterns evaluation provides novel insights for personalized immunotherapy compared to neoadjuvant chemotherapy in lung adenocarcinama
por: Cai, Liangliang, et al.
Publicado: (2023)

Molecular typing and prognostic model of lung adenocarcinoma based on cuprotosis-related lncRNAs
por: Zheng, Miaosen, et al.
Publicado: (2022)

A novel prognostic prediction model of cuprotosis-related genes signature in hepatocellular carcinoma
por: Shao, Ruo-Nan, et al.
Publicado: (2023)

Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes
por: Wang, Guangyao, et al.
Publicado: (2023)

Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients
por: Chi, Hao, et al.
Publicado: (2022)

Systematic analysis of the cuprotosis in tumor microenvironment and prognosis of gastric cancer
por: Wang, Ke-wei, et al.
Publicado: (2023)

Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer
por: Xu, Ximo, et al.
Publicado: (2023)

FDX1 inhibits thyroid cancer malignant progression by inducing cuprotosis
por: Chen, Gaoxiang, et al.
Publicado: (2023)

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients
por: Tian, Yanhua, et al.
Publicado: (2020)

Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients
por: Xu, Yingkun, et al.
Publicado: (2022)

Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer
por: Cai, Liangliang, et al.
Publicado: (2019)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Machine learning-based characterization of cuprotosis-related biomarkers and immune infiltration in Parkinson’s disease
por: Zhao, Songyun, et al.
Publicado: (2022)

Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma
por: Gao, Yiren, et al.
Publicado: (2022)

Global status and research trends of cuprotosis research: A bibliometrics study via CiteSpace
por: Xie, Xiaoli, et al.
Publicado: (2023)

Estimating disease-free survival of thyroid cancer based on novel cuprotosis-related gene model
por: Du, Rui, et al.
Publicado: (2023)

Identification of core cuprotosis-correlated biomarkers in abdominal aortic aneurysm immune microenvironment based on bioinformatics
por: Hu, Jiateng, et al.
Publicado: (2023)

Construction of a Cuprotosis-Related Gene-Based Model to Improve the Prognostic Evaluation of Patients with Gastric Cancer
por: Han, Chunyan, et al.
Publicado: (2022)

Identification of cuprotosis-mediated subtypes, the development of a prognosis model, and influence immune microenvironment in hepatocellular carcinoma
por: Xiao, Jingjing, et al.
Publicado: (2022)

Differences in Immunological Landscape between EGFR-Mutated and Wild-Type Lung Adenocarcinoma
por: Luo, Jia-Wei, et al.
Publicado: (2021)

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma
por: Bai, Hua, et al.
Publicado: (2020)

A novel Cuprotosis-related signature predicts the prognosis and selects personal treatments for melanoma based on bioinformatics analysis
por: Hu, Bingqian, et al.
Publicado: (2023)

BAIAP2L2 is a novel prognostic biomarker related to migration and invasion of HCC and associated with cuprotosis
por: Wei, Hui, et al.
Publicado: (2023)

Exploration of cuprotosis-related genes for predicting prognosis and immunological characteristics in acute myeloid leukaemia based on genome and transcriptome
por: Wei, Yanhui, et al.
Publicado: (2023)

The potential value of cuprotosis in myocardial immune infiltration that occurs in pediatric congenital heart disease in response to surgery with cardiopulmonary bypass
por: Puwei, Song, et al.
Publicado: (2023)

The transcriptional landscape and mutational profile of lung adenocarcinoma
por: Seo, Jeong-Sun, et al.
Publicado: (2012)

A Novel Cuprotosis-Related Gene FDX1 Signature for Overall Survival Prediction in Clear Cell Renal Cell Carcinoma Patients
por: Zhang, Wei-Tong, et al.
Publicado: (2022)

A prognostic signature based on cuprotosis-related long non-coding RNAs predicts the prognosis and sensitivity to chemotherapy in patients with colorectal cancer
por: Li, Wei, et al.
Publicado: (2022)

The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
por: Xie, Lu, et al.
Publicado: (2021)

The global landscape of intron retentions in lung adenocarcinoma
por: Zhang, Qu, et al.
Publicado: (2014)

ROS1 Fusion Mediates Immunogenicity by Upregulation of PD-L1 After the Activation of ROS1–SHP2 Signaling Pathway in Non-Small Cell Lung Cancer
por: Cai, Liangliang, et al.
Publicado: (2020)

Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma
por: Li, Zhenxiang, et al.
Publicado: (2015)

The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma
por: Zhang, Xiulei, et al.
Publicado: (2020)

Role of tumor mutation burden-related signatures in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

The Status of the EGFR T790M Mutation is associated with the Clinical Benefits of Osimertinib Treatment in Non-small Cell Lung Cancer Patients: A Meta-Analysis
por: Zhao, Zhe, et al.
Publicado: (2020)

Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
por: Lundgren, Sebastian, et al.
Publicado: (2019)

Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma
por: Yekedüz, Emre, et al.
Publicado: (2022)

Genomic landscape and evolution of arm aneuploidy in lung adenocarcinoma
por: Gao, Beili, et al.
Publicado: (2021)

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden
por: Georgoulias, George, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qc4766qkarctkqee12i0958nqh